Lotte Biologics, a South Korean contract development and manufacturing organization, and Merck’s process solutions arm signed a letter of intent for a strategic partnership in biopharmaceutical manufacturing and process development, the company said Friday. Under the partnership, Lotte Biologics plans to purchase raw materials and solutions from Merck for its development and production of pharmaceutical product.
EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.
Lotte Group Chairman Shin Dong-bin is seeking ways to strengthen corporate competitiveness amid the global economic downturn, according to the company, Thursday. Lotte held the 2023 Lotte Value Creation Meeting (VCM), at Lotte World Tower in Seoul, Thursday, and discussed group management plans and medium- to long-term strategies as global market volatility and uncertainty are on the rise.